Michael Braun, Ph.D., is currently Director of Late Oral Drug Product Development at Boehringer Ingelheim Pharma GmbH & Co KG in Biberach, Germany. Michael has a Ph.D in Pharmaceutical Technology from University of Bonn, Germany. His career is spanning over 25 years in pharmaceutical R&D, from hands-on formulation work to strategic leadership in drug development and manufacturing. Michael's journey began in 1999 as a Formulation Scientist at Ratiopharm and later as Head of Pharmaceutical Development at Rentschler Pharma in 2003. His career has evolved through various roles in early and late stage drug product development, clinical trial manufacturing and project management at Boehringer Ingelheim since 2006. Over the past two years Michael has worked at the Ridgefield Site, CT as the Director of Solid-State Sciences & API Engineering, driving innovation at the interface of drug substance and product development.